Literature DB >> 16718519

Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation.

Dongxia Li1, Belur N Manjula, A Seetharama Acharya.   

Abstract

Human hemoglobin (Hb) conjugated with six copies of PEG-5K is nonhypertensive. The hexaPEGylated Hb exhibits molecular size homogeneity in spite of the chemical heterogeneity with respect to the sites of conjugation (Manjula et al., 2005). In the present study, Hb conjugated with an average of 4, 6, 8 and 10 copies of PEG-5K chains have been generated using the extension arm facilitated PEGylation protocol. Except for the tetraPEGylated Hb, all the other products exhibit molecular size homogeneity. The molecular, colligative and functional properties of PEG-Hb conjugates have been correlated with the extent of PEGylation. The results imply that six copies of PEG-5K chains are accommodated on Hb without significant crowding on the molecular surface. As more copies of PEG-5K chains are conjugated to form octa and deca PEGylated Hb, the PEG-chains conjugated appear to undergo transition from a mushroom (compact) to a brush-like conformation (extended conformation) with a concomitant decrease in the propensity of the molecule to transition from oxy to deoxy conformation in the presence of allosteric effectors. The viscosity and the colloidal osmotic pressure of Hb increase with the number of the PEG-chains conjugated in an exponential fashion. The composition of the PEGylated Hb generated appears to be controlled by (i) high reactivity of thiol groups of the extension arms on Hb with maleimide-PEG, (ii) increase in the viscosity of the reaction mixture as the level of PEGylation increases and (iii) increased resistance induced by the PEG-shell of PEGylated Hb to accommodate more PEG-chains as the level of PEGylation increases. Potential implications of extent of PEGylation on the oxygen delivery by PEG-Hb conjugate in vivo have been discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718519     DOI: 10.1007/s10930-006-9010-y

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  21 in total

Review 1.  Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology.

Authors:  J G Riess
Journal:  Chem Rev       Date:  2001-09       Impact factor: 60.622

Review 2.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

3.  Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.

Authors:  Tao Hu; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

4.  Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model.

Authors:  R M Winslow; A Gonzales; M L Gonzales; M Magde; M McCarthy; R J Rohlfs; K D Vandegriff
Journal:  J Appl Physiol (1985)       Date:  1998-09

5.  Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide.

Authors:  R J Rohlfs; E Bruner; A Chiu; A Gonzales; M L Gonzales; D Magde; M D Magde; K D Vandegriff; R M Winslow
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

6.  Cys-93-betabeta-succinimidophenyl polyethylene glycol 2000 hemoglobin A. Intramolecular cross-bridging of hemoglobin outside the central cavity.

Authors:  B N Manjula; A Malavalli; P K Smith; N L Chan; A Arnone; J M Friedman; A S Acharya
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  Microvascular PO2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(beta) in hamster window chamber.

Authors:  Pedro Cabrales; Nirmala Devi Kanika; Belur N Manjula; Amy G Tsai; Seetharama A Acharya; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-10       Impact factor: 4.733

8.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Authors:  A Abuchowski; T van Es; N C Palczuk; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

Review 9.  Chemistry for peptide and protein PEGylation.

Authors:  M J Roberts; M D Bentley; J M Harris
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

10.  Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier.

Authors:  A Yabuki; K Yamaji; H Ohki; Y Iwashita
Journal:  Transfusion       Date:  1990 Jul-Aug       Impact factor: 3.157

View more
  8 in total

1.  Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin.

Authors:  Tao Hu; Belur N Manjula; Dongxia Li; Michael Brenowitz; Seetharama A Acharya
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

2.  Tangential flow filtration of hemoglobin.

Authors:  Andre F Palmer; Guoyong Sun; David R Harris
Journal:  Biotechnol Prog       Date:  2009 Jan-Feb

3.  Site-selective glycosylation of hemoglobin on Cys beta93.

Authors:  Yalong Zhang; Veer S Bhatt; Guoyong Sun; Peng G Wang; Andre F Palmer
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

4.  PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.

Authors:  Fantao Meng; Amy G Tsai; Marcos Intaglietta; Seetharama A Acharya
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-03-06       Impact factor: 5.678

5.  Improving cardiac function with new-generation plasma volume expanders.

Authors:  Surapong Chatpun; Parimala Nacharaju; Pedro Cabrales
Journal:  Am J Emerg Med       Date:  2012-08-03       Impact factor: 2.469

6.  Polyethylene Glycol Camouflaged Earthworm Hemoglobin.

Authors:  Vivek P Jani; Alborz Jelvani; Selamawit Moges; Parimala Nacharaju; Camille Roche; David Dantsker; Andre Palmer; Joel M Friedman; Pedro Cabrales
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

7.  A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease.

Authors:  Luca Ronda; Marialaura Marchetti; Riccardo Piano; Anastasia Liuzzi; Romina Corsini; Riccardo Percudani; Stefano Bettati
Journal:  Pharm Res       Date:  2017-05-15       Impact factor: 4.200

8.  High- and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model.

Authors:  Esra'a Alomari; Luca Ronda; Stefano Bruno; Gianluca Paredi; Marialaura Marchetti; Stefano Bettati; Davide Olivari; Francesca Fumagalli; Deborah Novelli; Giuseppe Ristagno; Roberto Latini; Chris E Cooper; Brandon J Reeder; Andrea Mozzarelli
Journal:  Free Radic Biol Med       Date:  2018-06-18       Impact factor: 7.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.